[LGND] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 1,668.52%
YoY- 1,371.62%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 27,003 24,808 24,987 43,484 59,590 45,663 90,043 -55.09%
PBT -8,175 -19,871 -18,028 842,713 -56,789 79,226 95,579 -
Tax -810 -4,620 -3,609 176,376 -14,307 11,864 22,419 -
NP -7,365 -15,251 -14,419 666,337 -42,482 67,362 73,160 -
Tax Rate - - - -20.93% - -14.97% -23.46% -
Total Cost 34,368 40,059 39,406 -622,853 102,072 -21,699 16,883 60.41%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -27.27 -61.48 -57.71 1,532.37 -71.29 147.52 81.25 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.43 -0.81 -0.74 32.59 -2.02 3.19 3.45 -
EPS Diluted -0.43 -0.81 -0.74 31.32 -2.02 2.80 2.99 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.